Cargando…

Constitutive Nuclear Factor κB Activity Is Required for Survival of Activated B Cell–like Diffuse Large B Cell Lymphoma Cells

Gene expression profiling has revealed that diffuse large B cell lymphoma (DLBCL) consists of at least two distinct diseases. Patients with one DLBCL subtype, termed activated B cell–like (ABC) DLBCL, have a distinctly inferior prognosis. An untapped potential of gene expression profiling is its abi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, R. Eric, Brown, Keith D., Siebenlist, Ulrich, Staudt, Louis M.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2001
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193582/ https://www.ncbi.nlm.nih.gov/pubmed/11748286

Ejemplares similares

Constitutive NF-κB Activation Underlines Major Mechanism of Drug Resistance in Relapsed Refractory Diffuse Large B Cell Lymphoma
por: Turturro, Francesco
Publicado: (2015)

Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell–like diffuse large B cell lymphoma
por: Lenz, Georg, et al.
Publicado: (2007)

Bruton's Tyrosine Kinase Is Required for Activation of Iκb Kinase and Nuclear Factor κb in Response to B Cell Receptor Engagement
por: Petro, James B., et al.
Publicado: (2000)

17-Aminogeldanamycin Inhibits Constitutive Nuclear Factor-Kappa B (NF-κB) Activity in Patient-Derived Melanoma Cell Lines
por: Hartman, Mariusz L., et al.
Publicado: (2020)

NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
por: Jayawant, Eleanor, et al.
Publicado: (2023)

Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
por: Autio, Matias, et al.
Publicado: (2020)

PI3Kδ inhibition causes feedback activation of PI3Kα in the ABC subtype of diffuse large B-cell lymphoma
por: Pongas, Georgios N., et al.
Publicado: (2017)

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
por: Zhang, Mingzhi, et al.
Publicado: (2016)

Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma
por: Derenzini, Enrico, et al.
Publicado: (2015)

Characterizing the role of the alternative NF-κB pathway in diffuse large B-cell lymphoma
por: Ito, Daisuke, et al.
Publicado: (2013)

Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines
por: Hussain, Azhar R., et al.
Publicado: (2011)

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma
por: Yang, David T, et al.
Publicado: (2008)

A homeostatic model of IκB metabolism to control constitutive NF-κB activity
por: O'Dea, Ellen L, et al.
Publicado: (2007)

Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells
por: Wu, Chun-Hsien, et al.
Publicado: (2018)

Targeting constitutive NF-κB specifically in tumor cells
por: Jeong, Ji-Hak, et al.
Publicado: (2017)

The Truncate Mutation of Notch2 Enhances Cell Proliferation through Activating the NF-κB Signal Pathway in the Diffuse Large B-Cell Lymphomas
por: Zhang, Xinxia, et al.
Publicado: (2014)

Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-κB pathway and promotes lymphomagenesis
por: Hömig-Hölzel, Cornelia, et al.
Publicado: (2008)

Bruton's Tyrosine Kinase Links the B Cell Receptor to Nuclear Factor κb Activation
por: Bajpai, Urmila D., et al.
Publicado: (2000)

Inhibition of MALT1 protease activity is selectively toxic for activated B cell–like diffuse large B cell lymphoma cells
por: Ferch, Uta, et al.
Publicado: (2009)

Inhibition of MALT1 protease activity is selectively toxic for activated B cell–like diffuse large B cell lymphoma cells
por: Ferch, Uta, et al.
Publicado: (2009)

T cell-NF-κB activation is required for tumor control in vivo
por: Barnes, Sarah E, et al.
Publicado: (2015)

NF-κB Mutations in Germinal Center B-Cell Lymphomas: Relation to NF-κB Function in Normal B Cells
por: Pasqualucci, Laura, et al.
Publicado: (2022)

The roles of the classical and alternative nuclear factor-kappaB pathways: potential implications for autoimmunity and rheumatoid arthritis
por: Brown, Keith D, et al.
Publicado: (2008)

CAR-T Cell Therapy in Diffuse Large B Cell Lymphoma: Hype and Hope
por: Hopfinger, Georg, et al.
Publicado: (2019)

Inflammatory Cells in Diffuse Large B Cell Lymphoma
por: Tamma, Roberto, et al.
Publicado: (2020)

Insights into the Molecular Pathogenesis of Activated B-Cell-like Diffuse Large B-Cell Lymphoma and Its Therapeutic Implications
por: Lenz, Georg
Publicado: (2015)

A20 Mutation Is Not a Prognostic Marker for Activated B-Cell-Like Diffuse Large B-Cell Lymphoma
por: Cen, Hong, et al.
Publicado: (2015)

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
por: Priebe, Valdemar, et al.
Publicado: (2020)

Lenalidomide in Diffuse Large B-Cell Lymphomas
por: Chiappella, Annalisa, et al.
Publicado: (2012)

Treatment of Diffuse Large B Cell Lymphoma
por: Kwak, Jae-Yong
Publicado: (2012)

Lenalidomide in Diffuse Large B-Cell Lymphoma
por: Thieblemont, Catherine, et al.
Publicado: (2012)

Cutaneous diffuse large B‐cell lymphoma
por: Duarte Ribeiro, Filipa, et al.
Publicado: (2017)

Genomics of diffuse large B cell lymphoma
por: Koh, Youngil
Publicado: (2021)

Diffuse Large B-Cell Lymphoma of the Cecum
por: Azad, Farhan, et al.
Publicado: (2023)

Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma
por: Rosenwald, Andreas, et al.
Publicado: (2003)

Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas
por: Bognar, M K, et al.
Publicado: (2016)

mTOR activity in AIDS-related diffuse large B-cell lymphoma
por: Browne, Sara H., et al.
Publicado: (2017)

BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma
por: Yuan, Hongwei, et al.
Publicado: (2022)

Nuclear Factor κb Is Required for the Development of Marginal Zone B Lymphocytes
por: Cariappa, Annaiah, et al.
Publicado: (2000)

Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Subtype of the Thyroid
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbgb60v4a6ttr20074qteha7q7